stoxline Quote Chart Rank Option Currency Glossary
  
BlackRock Health Sciences Trust (BME)
40.04  -0.04 (-0.1%)    05-24 16:00
Open: 40.08
High: 40.25
Volume: 22,644
  
Pre. Close: 40.08
Low: 40
Market Cap: 503(M)
Technical analysis
2024-05-27 4:44:28 PM
Short term     
Mid term     
Targets 6-month :  47.32 1-year :  55.27
Resists First :  40.51 Second :  47.32
Pivot price 40.09
Supports First :  39.48 Second :  38.84
MAs MA(5) :  40.23 MA(20) :  39.91
MA(100) :  40.99 MA(250) :  39.92
MACD MACD :  0.1 Signal :  0
%K %D K(14,3) :  67 D(3) :  78.6
RSI RSI(14): 51.7
52-week High :  42.86 Low :  35.52
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BME ] has closed above bottom band by 42.6%. Bollinger Bands are 66.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 40.34 - 40.58 40.58 - 40.76
Low: 39.41 - 39.74 39.74 - 39.98
Close: 39.61 - 40.09 40.09 - 40.45
Company Description

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Headline News

Wed, 22 May 2024
Truist Financial Corp Invests $213000 in BlackRock Health Sciences Trust (NYSE:BME) - Defense World

Thu, 09 May 2024
Long Term Trading Analysis for (BME) - Stock Traders Daily

Tue, 07 May 2024
International Assets Investment Management LLC Makes New Investment in BlackRock Health Sciences Trust (NYSE ... - Defense World

Tue, 30 Apr 2024
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions - Business Wire

Mon, 08 Jan 2024
BME Vs. THW: A Distribution Cut Should Widen The Performance Gap - Seeking Alpha

Sun, 17 Sep 2023
BME: Blackrock's Health Sciences Fund Is A Solid Alternative To Pricey THW (NYSE:BME) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Financial Services
Industry:
Asset Management
Shares Out 14 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 21.1 (%)
Shares Short 5 (K)
Shares Short P.Month 9 (K)
Stock Financials
EPS 1.44
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 42.18
Profit Margin 244.3 %
Operating Margin 21.1 %
Return on Assets (ttm) 0.2 %
Return on Equity (ttm) 3.3 %
Qtrly Rev. Growth -0.9 %
Gross Profit (p.s.) 0
Sales Per Share 0.58
EBITDA (p.s.) 0
Qtrly Earnings Growth -75.9 %
Operating Cash Flow 32 (M)
Levered Free Cash Flow 5 (M)
Stock Valuations
PE Ratio 27.8
PEG Ratio 0
Price to Book value 0.94
Price to Sales 68.15
Price to Cash Flow 17.43
Stock Dividends
Dividend 0.2
Forward Dividend 0
Dividend Yield 0.5%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android